J. Llorca

发表

Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis

M. Gonzalez-gay, A. Sánchez-Andrade, C. González-Juanatey, 2006 .

Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review

M. González-Gay, M. Gonzalez-gay, R. Blanco, 2012, Lupus.

Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.

M. González-Gay, J. Llorca, M. González‐Gay, 2001, Seminars in arthritis and rheumatism.

Implications of upper respiratory tract infections and drugs in the clinical spectrum of Henoch-Schönlein purpura in children.

M. González-Gay, J. Llorca, M. Vázquez-López, 2004, Clinical and experimental rheumatology.

Lack of association between altitude and incidence of giant cell arteritis in Northwest Spain.

M. González-Gay, M. Bringas-Bollada, J. Llorca, 2004, Clinical and experimental rheumatology.

High-grade infl ammation , circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis

P. Dessein, M. Gonzalez-gay, G. Norton, 2006 .

Predictors of cerebrovascular accidents in giant cell arteritis in a defined population.

M. González-Gay, J. Llorca, R. Pego-Reigosa, 2004, Clinical and experimental rheumatology.

Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy.

M. González-Gay, C. González-Juanatey, T. Vázquez-Rodríguez, 2010, Clinical and experimental rheumatology.

Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis.

M. González-Gay, P. Dessein, C. González-Juanatey, 2009, Clinical and experimental rheumatology.

Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab.

M. Gonzalez-gay, A. Sánchez-Andrade, C. González-Juanatey, 2006, Clinical and experimental rheumatology.

Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis.

M. González-Gay, P. Dessein, C. González-Juanatey, 2008, Clinical and experimental rheumatology.

Anti-TNF-α therapy modulates resistin in patients with rheumatoid arthritis

P. Dessein, M. Gonzalez-gay, C. González-Juanatey, 2008 .

Anti-TNF-α therapy does not modulate leptin in patients with severe rheumatoid arthritis

M. González-Gay, P. Dessein, C. González-Juanatey, 2009 .

Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.

M. González-Gay, A. Sánchez-Andrade, C. González-Juanatey, 2006, Clinical and experimental rheumatology.

Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.

W. Ollier, M. González-Gay, J. Llorca, 2004, Rheumatology.

Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis.

M. González-Gay, P. Dessein, C. González-Juanatey, 2009, Clinical and experimental rheumatology.

Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis.

M. Gonzalez-gay, R. Blanco, C. González-Juanatey, 2013, Clinical and experimental rheumatology.

Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis.

M. González-Gay, J. Llorca, C. González-Juanatey, 2009, Clinical and experimental rheumatology.

Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis.

M. González-Gay, B. Fernández-Gutiérrez, A. Balsa, 2010, Clinical and experimental rheumatology.

THU0219 Beneficial effect of anti-il-6 blockade on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis

M. González-Gay, S. Castañeda, J. Calvo-Alén, 2018, THURSDAY, 14 JUNE 2018.

Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period

M. González-Gay, J. Llorca, C. García‐Porrúa, 2001, Annals of the rheumatic diseases.

Implication of the age in the clinical spectrum of giant cell arteritis.

M. González-Gay, C. González-Juanatey, J. Llorca, 2008, Clinical and experimental rheumatology.

Predictive factors for renal sequelae in adults with Henoch-Schönlein purpura.

J. Llorca, M. Gonzalez-gay, J. Llorca, 2001, The Journal of rheumatology.

Hypersensitivity vasculitis in adults: a benign disease usually limited to skin.

M. Gonzalez-gay, J. Llorca, C. García‐Porrúa, 2001, Clinical and experimental rheumatology.

Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain.

M. González-Gay, C. González-Juanatey, J. Martín, 2010, Clinical and Experimental Rheumatology.

Assessment of physical functioning in patients with chronic obstructive pulmonary disease (COPD) requiring long-acting dual bronchodilation in routine clinical practice.

J. París, J. Llorca, X. Ribera, 2020, Semergen.

Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis

M. González-Gay, P. Dessein, J. Llorca, 2017, Clinical Rheumatology.

Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis.

M. González-Gay, L. Rodríguez-Rodríguez, I. González-Álvaro, 2011, Clinical and experimental rheumatology.

Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis.

M. González-Gay, I. Gómez-Acebo, C. González-Juanatey, 2009, Clinical and experimental rheumatology.

High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis.

P. Dessein, M. Gonzalez-gay, G. Norton, 2008, Clinical and experimental rheumatology.

Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index.

C. Magro-Checa, M. Gonzalez-gay, J. Llorca, 2014, Clinical and experimental rheumatology.

Lack of association between adipokines and ghrelin and carotid intima-media thickness in patients with severe rheumatoid arthritis.

L. Rodríguez-Rodríguez, M. Gonzalez-gay, C. González-Juanatey, 2011, Clinical and experimental rheumatology.

Quality of Life and Post-Surgical Complications in Patients on Chronic Antiplatelet Therapy with Proximal Femur Fracture: 12-Month Follow-Up after Implementing a Strategy to Shorten the Time to Surgery

M. Martínez-Zapata, J. Llorca, José Gil, 2023, Journal of clinical medicine.

Early Surgery with Neuraxial Anaesthesia in Patients on Chronic Antiplatelet Therapy with a Proximal Femur Fracture: Multicentric Randomised Clinical Trial

M. Martínez-Zapata, J. Llorca, V. Moral, 2021, Journal of Clinical Medicine.

Trends in the inflammatory response in biopsy-proven giant cell arteritis: comment on the article by Cid et al, and the letters by Nesher and Sonnenblick and Liozon et al.

M. Gonzalez-gay, J. Llorca, C. García‐Porrúa, 2000, Arthritis and rheumatism.

Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis.

E. Urcelay, M. González-Gay, L. Rodríguez-Rodríguez, 2012, Clinical and experimental rheumatology.

AB0021 Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in spanish rheumatoid arthritis patients

I. González-Álvaro, M. Gonzalez-gay, C. González-Juanatey, 2013 .